Verve Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2020	FY 2019	FY 2013	FY 2012	FY 2011	2015
Period Ending	Aug '25 Aug 1, 2025	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '13 Dec 31, 2013	Dec '12 Dec 31, 2012	Dec '11 Dec 31, 2011	2015
Market Capitalization	3	39	0	0	0	2	Upgrade
Market Cap Growth	25899.23%	9900.01%	263.99%	-44.44%	-90.27%	36.54%	Upgrade
Enterprise Value	-	40	2	1	1	2	Upgrade
Last Close Price	0.00	0.02	0.00	0.00	0.00	0.01	Upgrade
PE Ratio	-	-	0.44	-	-	-	Upgrade
PS Ratio	-	-	1254.75	0.67	1.10	-	Upgrade
PB Ratio	-0.01	-0.16	-0.04	-0.02	-0.04	-0.66	Upgrade
EV/Sales Ratio	-	-	4808.70	5.98	5.91	-	Upgrade
Debt / Equity Ratio	-0.02	-0.02	-0.16	-0.23	-0.25	-0.28	Upgrade
Asset Turnover	-	-	-	0.42	0.43	-	Upgrade
Quick Ratio	0.00	0.00	-	0.03	0.04	-	Upgrade
Current Ratio	0.01	0.01	-	0.03	0.04	-	Upgrade
Return on Assets (ROA)	-29.16%	-29.16%	-	-45.38%	-134.40%	-320.03%	Upgrade
Earnings Yield	-7617.38%	-591.90%	227.68%	-255.25%	-913.62%	-51.99%	Upgrade
Buyback Yield / Dilution	-274.45%	-	-	-52.14%	-104.70%	-	Upgrade

Updated Jul 15, 2014. Source: S&P Global Market Intelligence. Standard template. Financial Sources.